SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-019766
Filing Date
2023-12-14
Accepted
2023-12-14 07:15:59
Documents
15
Period of Report
2023-12-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nxtc-20231214x8k.htm   iXBRL 8-K 47202
2 EX-99.1 nxtc-20231214xex99d1.htm EX-99.1 23175
3 GRAPHIC nxtc-20231214xex99d1001.jpg GRAPHIC 6578
  Complete submission text file 0001558370-23-019766.txt   217151

Data Files

Seq Description Document Type Size
4 EX-101.SCH nxtc-20231214.xsd EX-101.SCH 4009
5 EX-101.DEF nxtc-20231214_def.xml EX-101.DEF 2852
6 EX-101.LAB nxtc-20231214_lab.xml EX-101.LAB 17908
7 EX-101.PRE nxtc-20231214_pre.xml EX-101.PRE 11818
9 EXTRACTED XBRL INSTANCE DOCUMENT nxtc-20231214x8k_htm.xml XML 5082
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38905 | Film No.: 231485555
SIC: 2834 Pharmaceutical Preparations